Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Afya Ltd. (AFYA:NASDAQ), powered by AI.
Afya Ltd. is currently trading at $14.02. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Afya Ltd. on Alpha Lenz.
Afya Ltd.'s P/E ratio is 1.7.
“Afya Ltd. trades at a P/E of 1.7 (undervalued) with strong ROE of 16.5%. 3Y revenue CAGR of 16.7% highlights clear growth momentum.”
Ask for details →Afya Ltd. operates as a leading consolidator and provider within the Brazilian medical education sector. Specializing in the development and delivery of medical education services, the company plays a vital role in training healthcare professionals by offering undergraduate and graduate programs in medicine, as well as related healthcare disciplines. Afya Ltd. stands out for its comprehensive educational solutions that combine traditional classroom learning with cutting-edge digital tools, ensuring students gain the requisite skills and knowledge to excel in the healthcare industry. The company's reach extends across Brazil, where there is a growing demand for qualified healthcare professionals, directly impacting the healthcare and education sectors. By focusing on medical education, Afya Ltd. contributes significantly to addressing the needs of Brazil's expanding healthcare market. In a country with a diverse and dynamic healthcare backdrop, Afya Ltd. plays an essential aggregator role, supporting the continuum of education from entry-level medical training to advanced specialties. This positions the company as a pivotal player in shaping the future landscape of medical expertise in Brazil.
“Afya Ltd. trades at a P/E of 1.7 (undervalued) with strong ROE of 16.5%. 3Y revenue CAGR of 16.7% highlights clear growth momentum.”
Ask for details →Afya Ltd. (ticker: AFYA) is a company listed on NASDAQ in the Consumer Defensive sector (Education & Training Services). Market cap is $1.3B.
The current price is $14.02 with a P/E ratio of 1.69x and P/B of 0.26x.
ROE is 16.50% and operating margin is 32.81%. Annual revenue is $3.7B.